Trials / Completed
CompletedNCT03337347
Clinical Significance of Detecting CEA and CK20 mRNA-positive Cells in Colorectal Cancer Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 256 (actual)
- Sponsor
- The Institute of Molecular and Translational Medicine, Czech Republic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To determine whether the presence of circulating/disseminated tumor cells (CTCs/DTCs) in the blood and bone marrow of colorectal cancer (CRC) patients with localized disease is a negative prognostic factor, and to find correlations with other clinical/pathological disease characteristics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CTC/DTC count | The presence of CTCs/DTCs in the peripheral blood and/or bone marrow may identify colorectal cancer patients with high risk of disease recurrence who may benefit from adjuvant therapy. |
Timeline
- Start date
- 2004-01-01
- Primary completion
- 2007-02-28
- Completion
- 2015-10-23
- First posted
- 2017-11-09
- Last updated
- 2019-10-15
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT03337347. Inclusion in this directory is not an endorsement.